The Department of Health and Human Services and other federal agencies should work through the Biodefense Steering Committee to ensure the Biodefense Coordination Team defines the capabilities needed to prepare for and respond to significant biological incidents such as COVID-19; monitors and reports on findings from interagency exercises and real-world incidents; and recommends action to address identified challenges, according to a report released today by the Government Accountability Office. The Coronavirus Aid, Relief, and Economic Security Act called for GAO to review federal efforts to prepare for, respond to and recover from COVID-19. The agency reviewed interagency response plans and exercises and real biological incidents between 2009 and 2019 to identify opportunities to better achieve National Biodefense Strategy objectives.

Related News Articles

Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…